Stock DNA
Medical/Nursing Services
CAD 4 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.33
170.50%
-2.60
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Oct 2024)
Net Profit:
0 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.52%
0%
-18.52%
6 Months
-21.43%
0%
-21.43%
1 Year
-57.69%
0%
-57.69%
2 Years
-70.27%
0%
-70.27%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Awakn Life Sciences Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-56.90%
EBIT Growth (5y)
-220.59%
EBIT to Interest (avg)
-4.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-2.60
EV to EBIT
-1.43
EV to EBITDA
-1.44
EV to Capital Employed
-1.70
EV to Sales
3.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
KST
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Oct'24 - YoY
Oct'24
Oct'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.50
-0.70
28.57%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.40
-0.60
33.33%
Operating Profit Margin (Excl OI)
-128,565.40%
-23,321.60%
-10,524.38%
USD in Million.
Net Sales
YoY Growth in quarter ended Oct 2024 is 0.00% vs -100.00% in Oct 2023
Consolidated Net Profit
YoY Growth in quarter ended Oct 2024 is 33.33% vs 62.50% in Oct 2023
Annual Results Snapshot (Consolidated) - Jan'24
Jan'24
Jan'23
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-3.90
-5.30
26.42%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.70
-5.00
26.00%
Operating Profit Margin (Excl OI)
-44,939.40%
0.00%
-4,493.94%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2024 is 0.00% vs -100.00% in Jan 2023
Consolidated Net Profit
YoY Growth in year ended Jan 2024 is 26.00% vs 69.70% in Jan 2023
About Awakn Life Sciences Corp. 
Awakn Life Sciences Corp.
Medical/Nursing Services
No Details Available.
Company Coordinates 
No Company Details Available






